Success Metrics

Clinical Success Rate

93.3%

Based on 28 completed trials

Completion Rate

93%(28/30)

Active Trials

4(10%)

Results Posted

64%(18 trials)

Terminated

2(5%)

Phase Distribution

Ph not_applicable

44%

Ph phase_2

36%

Ph phase_3

Ph phase_1

Ph phase_4

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution38 total trials

Phase 1Safety & dosage

3(7.9%)

Phase 2Efficacy & side effects

14(36.8%)

Phase 3Large-scale testing

2(5.3%)

Phase 4Post-market surveillance

2(5.3%)

N/ANon-phased studies

17(44.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.4%

28 of 34 finished

Non-Completion Rate

17.6%

6 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(28)

Terminated(6)

Other(1)

Detailed Status

Completed28

Recruiting4

Withdrawn4

Terminated2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

93.3%

Most Advanced

Phase 4

Trials by Phase

Phase 13 (7.9%)

Phase 214 (36.8%)

Phase 32 (5.3%)

Phase 42 (5.3%)

N/A17 (44.7%)

Trials by Status

recruiting410%

completed2872%

unknown13%

withdrawn410%

terminated25%

Recent Activity

4 active trials

Showing 5 of 39

recruitingnot_applicable

Clinical Trials (39)

Showing 20 of 39 trialsScroll for more

NCT07147205Not Applicable

Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine

Recruiting

NCT07642856Not Applicable

Individualized Neuro-Modulation Paired With Cerebellar Therapy

Recruiting

NCT04101084Not Applicable

Rocking Chair Therapy in Elderly With Dementia: Its Effects on Agitation

Completed

NCT05866185Not Applicable

Improving Adherence to Homework During Therapy

Completed

NCT07161804Phase 4

Pilot RCT Using Homeopathic Medicines in ASD

Completed

NCT06514495Not Applicable

Differential Effects of in Vivo and Virtual Exposure Therapy in Agoraphobia

Recruiting

NCT07054697Phase 4

Pilot-RCT With Individualized Homeopathic Treatment in the Children With Autism Spectrum Disorder

Completed

NCT00090064Phase 2

MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder

Completed

NCT04077437Phase 3

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)

Completed

NCT03537014Phase 3

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

Completed

NCT02427568Phase 2

MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness

Completed

NCT02008396Phase 2

Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults

Completed

NCT01211405Phase 2

Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder

Completed

NCT02876172Phase 1

MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD

Completed

NCT05790239Phase 2

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Recruiting

NCT02102802

Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD

Completed

NCT04968938Phase 2

Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD

Withdrawn

NCT04073433Phase 1

Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)

Withdrawn

NCT04454684Phase 2

A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders

Withdrawn

NCT05173831Phase 2

Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans

Withdrawn

Drug Details

Intervention Type: OTHER
Total Trials: 39